Mankind Pharma Explained

Mankind Pharma Limited
Type:Public
Isin:INE634S01028
Founders:
Area Served:Worldwide
Location City:Okhla Phase III, Delhi
Location Country:India[2]
Industry:Pharmaceutical
Key People:
  • Ramesh Juneja (Chairman)
  • Rajeev Juneja (MD & Vice Chairman)
  • Sheetal Arora (CEO)
  • Arjun Juneja (COO)
Revenue: (FY24)
Operating Income: (FY24)
Net Income: (FY24)[3]
Num Employees:22,000+ (2023)[4]

Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.[5] [6] [7]

As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market,[8] where it is reportedly the fourth largest pharmaceutical company by domestic sales.[9] Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms,[10] Prega News in pregnancy test kits,[11] and Unwanted-72 in emergency contraception.[12]

History

Mankind Pharma was incorporated in 1991, and actively started its operations in 1995, with the contributions of two brothers, Ramesh C. Juneja and Rajeev Juneja, who established the company with a seed capital of .[13] [14] The company was started with 20 employees and launched in two states in the first year of its operation.[15] [16]

Mankind Pharma initially targeted price-sensitive drugs, with a focus on rural market;[17] its early products included antibacterial drug Zenflox and prescription antibiotic Moxikind CV, which were priced at a steep discount to the existing products in the market.[18] The company ventured into the over-the-counter segment in 2007, focusing primarily on sexual healthcare products.[19] [20]

The company acquired Magnet Labs Pvt. Ltd. to enter the antipsychotic segment in 2007.[21] It acquired Longifene-an appetite stimulant for children in January 2010 which was earlier a brand of UCB.[22]

In 2017, Mankind Pharma established Pathkind Labs, a provider of diagnostics and healthcare tests.[23]

In 2019, Mankind became the first Indian company and second only in the world to develop and launch Dydrogesterone, a drug used in high-risk pregnancies and infertility by the brand name Dydroboon.[24]

In 2022, Mankind acquired Panacea Biotec Pharma's domestic formulations brands in India and Nepal for .[25] It then acquired a respiratory treatment product, and an infant skincare brand from Dr. Reddy's Laboratories.[26] It also bought a majority stake in the Ayurvedic and herbal products manufacturer, Upakarma Ayurveda.[27]

In 2022, the company entered agritech[28] and pet care segments.[29]

In April 2023, Mankind Pharma launched its initial public offering (IPO), with existing investors selling worth of shares.[30]

In 2024, Mankind Pharma acquired a 100% stake in Bharat Serums and Vaccines (BSV) from private equity firm Advent International for an enterprise value of .[31]

See also

External links

Notes and References

  1. News: Bhalla . Mohit . Rajagopal . Divya . Mankind Pharma: The story of Juneja siblings, the biggest disruptors in Indian pharma space . 21 December 2022 . The Economic Times.
  2. News: Singh . Khomba . Mankind Pharma's pocket-friendly pricing in demand . 21 December 2022 . The Economic Times.
  3. Web site: Investor Presentation Q4FY24 . Mankind Pharma . 15 May 2024.
  4. News: Mankind Pharma Forays Into Critical Care Segment . 12 April 2023 . Outlook India.
  5. News: India's Mankind Pharma wants deals, sees FY domestic sales topping $700 mln . 21 March 2023 . Reuters . 10 April 2015 . en.
  6. News: Raturi . Prerna . For a robust business . 7 May 2023 . Business Standard . 11 February 2012 . https://web.archive.org/web/20120427115436/http://business-standard.com/india/news/forrobust-business/157711/on/ . 27 April 2012.
  7. News: Singh . Raveena . At $6-7B, Mankind Pharma eyes Torrent's valuation. But its catch lies in Eris & Gland IPOs . 21 March 2023 . The Ken . 20 March 2023.
  8. News: India's biggest condom maker lifts dreary IPO market . 4 December 2023 . Financial Times. 27 April 2023.
  9. News: Raghunathan . Anu . Mankind Pharma's Founders Map Growth Plan After Pulling Off Major IPO . 4 December 2023 . Forbes . 11 October 2023. en.
  10. News: Tandon . Suneera . Durex becomes second-largest condom brand in India: Reckitt . 22 November 2022 . Mint . 18 February 2022 . en.
  11. News: Behind Mankind's plans to take Prega News to rural markets . 22 November 2022 . Moneycontrol . en.
  12. News: Mankind Pharma Ltd. . 24 April 2023 . Geojit.
  13. Web site: Mankind Pharma: Formulating Strategy To Enter The Big League . 8 May 2014. Shabana. Hussain. 27 June 2018.
  14. News: Mankind Pharma set to tap core drugs market . 26 April 2023 . Business Standard . 19 July 2012 . https://web.archive.org/web/20141006171322/http://www.business-standard.com/article/companies/mankind-pharma-set-to-tap-core-drugs-market-112071900076_1.html . 6 October 2014.
  15. Web site: A Giant Leap For Mankind . Business Outlook India . 2011-12-24 . 2013-02-05 . dead . https://web.archive.org/web/20120629041707/http://business.outlookindia.com/article.aspx?279322 . 29 June 2012 . dmy-all .
  16. News: Testing Times For Mankind Pharma . 26 April 2023 . Businessworld . en.
  17. News: Rajagopal . Divya . How Ramesh Juneja's Mankind Pharma has changed pharma game with pulp marketing . 1 March 2023 . The Economic Times . 13 June 2012.
  18. News: Mankind vs Goliaths . 26 April 2023 . Business Standard . 3 November 2009.
  19. News: Singh . Khomba . Mankind forays into OTC market . 27 April 2023 . The Economic Times . 3 March 2007.
  20. News: Singh . Rajiv . Mankind Pharma: Do products revolving around sex help the Rs 3000 cr company? . 26 April 2023 . The Economic Times . 26 March 2014.
  21. http://www.ijbmt.com/issue/333.pdf Acquisition of Magnet Labs
  22. https://web.archive.org/web/20120711023356/http://www.telegraphindia.com/1110829/jsp/frontpage/story_14438208.jsp Mankind Pharma markets Longifene- 29 August 2011
  23. News: Mankind Pharma forays into diagnostics . 26 April 2023 . The Times of India . 31 March 2017.
  24. News: Mankind Pharma launches drug for the treatment of infertility in India . 22 November 2022 . The Economic Times.
  25. News: Mankind Pharma acquires Panacea's domestic formulation brands for Rs 1,872 cr . 22 November 2022 . Business Today . 1 March 2022 . en.
  26. News: Mankind Pharma acquires two derma and respiratory brands from Dr. Reddy's . 22 November 2022 . Business Standard.
  27. News: Mahtta . Priyal . Mankind Pharma acquires majority stake in Upakarma Ayurveda . 3 December 2022 . mint . 28 November 2022 . en.
  28. News: Mankind Pharma forays into agri-tech space, plans to invest Rs 200 crore . 1 March 2023 . Business Standard . 5 April 2022 . en.
  29. News: Pilla . Viswanath . Mankind Pharma enters pet care segment with launch PetStar brand . 1 March 2023 . The Economic Times . 21 December 2022.
  30. News: Prabhakar . Sai . Mankind Pharma IPO: Why it's a promising prescription . 26 April 2023 . The Hindu Businessline . 22 April 2023 . en.
  31. News: Das . Sohini . Mankind Pharma acquires Bharat Serums and Vaccines for Rs 13,600 crore . 9 August 2024 . Business Standard . 26 July 2024.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Mankind Pharma".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.